LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 129 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $338,845 | -80.1% | 310,815 | -58.2% | 0.00% | -100.0% |
Q2 2023 | $1,702,491 | -2.6% | 743,737 | +3.4% | 0.00% | 0.0% |
Q1 2023 | $1,747,056 | +221607.6% | 719,182 | +74.2% | 0.00% | – |
Q4 2022 | $788 | -99.9% | 412,798 | -10.9% | 0.00% | – |
Q3 2022 | $1,111,000 | -10.3% | 463,188 | -30.3% | 0.00% | – |
Q2 2022 | $1,239,000 | -31.8% | 664,788 | -23.6% | 0.00% | -100.0% |
Q1 2022 | $1,818,000 | -40.3% | 869,611 | +12.5% | 0.00% | 0.0% |
Q4 2021 | $3,046,000 | +27.8% | 772,978 | +56.0% | 0.00% | 0.0% |
Q3 2021 | $2,383,000 | -4.1% | 495,438 | -8.5% | 0.00% | 0.0% |
Q2 2021 | $2,486,000 | +4261.4% | 541,655 | +3128.4% | 0.00% | – |
Q4 2020 | $57,000 | -10.9% | 16,778 | -49.0% | 0.00% | – |
Q1 2020 | $64,000 | +10.3% | 32,900 | +136.7% | 0.00% | – |
Q4 2019 | $58,000 | -84.4% | 13,900 | -55.3% | 0.00% | – |
Q1 2016 | $372,000 | -16.8% | 31,101 | -7.4% | 0.00% | – |
Q4 2015 | $447,000 | +23.8% | 33,602 | 0.0% | 0.00% | – |
Q3 2015 | $361,000 | +33.7% | 33,602 | 0.0% | 0.00% | – |
Q2 2015 | $270,000 | – | 33,602 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |